Biotrend Cevre ve Enerji Yatirimlari AS
IST:BIOEN.E
Intrinsic Value
Biotrend Çevre ve Enerji Yatirimlari AS engages in the energy generation from alternative resources. [ Read More ]
The intrinsic value of one
BIOEN.E
stock under the Base Case scenario is
14.24
TRY.
Compared to the current market price of 19.35 TRY,
Biotrend Cevre ve Enerji Yatirimlari AS
is
Overvalued by 26%.
Biotrend Cevre ve Enerji Yatirimlari AS's market capitalization is 9.7B TRY.
BIOEN.E stock price is 19.35 TRY.
BIOEN.E stock (14.24 TRY) is 26% less than its price (19.35 TRY).
BIOEN.E stock (7.81 TRY) is 60% less than its price (19.35 TRY). Open DCF Valuation
BIOEN.E stock price (19.35 TRY) is 6% less than its Relative Value (20.68 TRY). Open Relative Valuation
BIOEN.E has downside potential of 32% compared to the average analyst price target.
Open Wall St Estimates
BIOEN.E has positive three-year average ROIC (Return on Invested Capital): 10%. The company is efficient at using invested capital to generate operating income.
BIOEN.E's long-term assets (4B TRY) exceed its long-term liabilties (4B TRY).
BIOEN.E has positive Net Income for the last twelve months.
BIOEN.E's short-term liabilties (1B TRY) exceed its short-term assets (1B TRY).
BIOEN.E has positive Operating Income for the last twelve months.
BIOEN.E's Altman Z-Score is equal to 2.78.
BIOEN.E's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 26%.
BIOEN.E has positive Gross Profit for the last twelve months.
BIOEN.E's Revenue has grown by an exceptional 70% over the past 12 months.
BIOEN.E's ROE (Return on Equity) has significantly increased in the last 3 years from 14% to 109%.
BIOEN.E's ROIC (Return on Invested Capital) has significantly increased in the last 3 years from 3% to 26%.
BIOEN.E's ROE (Return on Equity) for the past 12 months is very high and is equal to 109%.
BIOEN.E has very high three-year average ROE (Return on Equity): 33%. The company is very efficient at transforming stockholders' equity into net income.
BIOEN.E has negative Free Cash Flow for the last twelve months.
BIOEN.E has positive Net Debt. This means that the company has more debt (2B TRY) than cash and short-term investments (208m TRY).
BIOEN.E's D/E (Debt to Equity) is very high and is equal to 4.27.
BIOEN.E generates enough operating income (354m TRY) to cover interest payments on its debt (117m TRY).
Valuation Backtest
Biotrend Cevre ve Enerji Yatirimlari AS
Run backtest to discover the historical profit from buying and selling
BIOEN.E
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Biotrend Cevre ve Enerji Yatirimlari AS
Balance Sheet Decomposition
Biotrend Cevre ve Enerji Yatirimlari AS
| Current Assets | 1.1B |
| Cash & Short-Term Investments | 207.6m |
| Receivables | 468.6m |
| Other Current Assets | 460.7m |
| Non-Current Assets | 3B |
| Long-Term Investments | 104.8m |
| PP&E | 2.3B |
| Intangibles | 49.6m |
| Other Non-Current Assets | 456.6m |
| Current Liabilities | 1.3B |
| Accounts Payable | 371.3m |
| Accrued Liabilities | 37.8m |
| Short-Term Debt | 239.9m |
| Other Current Liabilities | 635.2m |
| Non-Current Liabilities | 2.2B |
| Long-Term Debt | 2.2B |
| Other Non-Current Liabilities | 16m |
Earnings Waterfall
Biotrend Cevre ve Enerji Yatirimlari AS
|
Revenue
|
1.7B
TRY
|
|
Cost of Revenue
|
-1.2B
TRY
|
|
Gross Profit
|
482.1m
TRY
|
|
Operating Expenses
|
-127.6m
TRY
|
|
Operating Income
|
354.5m
TRY
|
|
Other Expenses
|
226.2m
TRY
|
|
Net Income
|
580.6m
TRY
|
Free Cash Flow Analysis
Biotrend Cevre ve Enerji Yatirimlari AS
| TRY | |
| Free Cash Flow | TRY |
BIOEN.E Profitability Score
Profitability Due Diligence
Biotrend Cevre ve Enerji Yatirimlari AS's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
Score
Biotrend Cevre ve Enerji Yatirimlari AS's profitability score is 62/100. The higher the profitability score, the more profitable the company is.
BIOEN.E Solvency Score
Solvency Due Diligence
Biotrend Cevre ve Enerji Yatirimlari AS's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Score
Biotrend Cevre ve Enerji Yatirimlari AS's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOEN.E Price Targets Summary
Biotrend Cevre ve Enerji Yatirimlari AS
According to Wall Street analysts, the average 1-year price target for
BIOEN.E
is 13.1 TRY
.
Shareholder Return
BIOEN.E Price
Biotrend Cevre ve Enerji Yatirimlari AS
| Average Annual Return | 117.12% |
| Standard Deviation of Annual Returns | 150% |
| Max Drawdown | -58% |
| Market Capitalization | 9.7B TRY |
| Shares Outstanding | 500 000 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Biotrend Cevre ve Enerji Yatirimlari AS
Country
Industry
Market Cap
Dividend Yield
Description
Biotrend Çevre ve Enerji Yatirimlari AS engages in the energy generation from alternative resources. The firm's main field of activity are biomass resources and fermentation energy generating, gasification, improving combustion technologies and operation of solid waste storage areas, ATY (waste-derived fuel) preparation facility, biological treatment (compost, biomethanization) facility, LFG (Landfill Gas) energy production plants, as well as the installation and operation of these plants. Entity provides also engineering, contracting and consultancy services in the mentioned fields. Biotrend has a total of 18 power plants, 15 of which are biogas, 2 are biomass and 1 is waste fuel preparation, and the total annual generation capacity of these plants is 411 kWh.
Contact
IPO
Employees
Officers
The intrinsic value of one
BIOEN.E
stock under the Base Case scenario is
14.24
TRY.
Compared to the current market price of 19.35 TRY,
Biotrend Cevre ve Enerji Yatirimlari AS
is
Overvalued by 26%.
You don't have any saved screeners yet
